Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CURI
22.26%
▲ 21.79%
NEXN
10.52%
▼ -0.34%
Gross Margin
CURI
72.84%
▲ 16.75%
NEXN
63.64%
▼ -17.43%
Free Cash Flow
CURI
-$4.16M
▼ -$5.37M
NEXN
$45.95M
▲ $75.28M
Net Debt / EBITDA
CURI
-0.18
▲ 1.76
NEXN
-1.06
▼ -0.37
Operating Margin
CURI
39.49%
▲ 49.68%
NEXN
4.14%
▲ 9.74%
P/E Ratio
CURI
9840.34
NEXN
49.86
▲ 25.02